Evidence map›Paper›PMID 34069436›Full record

ArticleMedicina (Kaunas, Lithuania)2021

Post-Progression Survival Is Strongly Associated with Overall Survival in Patients Exhibiting Postoperative Relapse of Non-Small-Cell Lung Cancer Harboring Sensitizing

Hisao Imai, Ryoichi Onozato, Maiko Ginnan, Daijiro Kobayashi, Kyoichi Kaira, Koichi Minato

Open access · goldAbstract read
In one paragraph

Article in Medicina (Kaunas, Lithuania), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Hisao ImaiGunma Prefectural Cancer Center, Division of Respiratory Medicine, Ota, Gunma 373-8550, Japan.ORCID 0000-0003-3097-4255
Ryoichi OnozatoGunma Prefectural Cancer Center, Division of Thoracic Surgery, Ota, Gunma 373-8550, Japan.
Maiko GinnanGunma Prefectural Cancer Center, Division of Pharmacy, Ota, Gunma 373-8550, Japan.
Daijiro KobayashiGunma Prefectural Cancer Center, Division of Radiation Oncology, Ota, Gunma 373-8550, Japan.
Kyoichi KairaComprehensive Cancer Center, International Medical Center, Department of Respiratory Medicine, Saitama Medical University, Hidaka, Saitama 350-1298, Japan.ORCID 0000-0001-5548-7686
Koichi MinatoGunma Prefectural Cancer Center, Division of Respiratory Medicine, Ota, Gunma 373-8550, Japan.
Saitama Medical University · JPHyogo Prefectural Cancer Center · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Carcinoma, Non-Small-Cell LungLung NeoplasmsErbB ReceptorsHumansMutationNeoplasm StagingProspective StudiesProtein Kinase InhibitorsRecurrenceSurvival RateTreatment OutcomeEGFR protein, humanErbB ReceptorsProtein Kinase InhibitorsEGFR mutationEGFR-TKInon-small-cell lung canceroverall survivalpostoperative relapsepost-progression survivalrelapse-free survival

Identifiers

PMID34069436
PMCPMC8159079
OpenAlexW3162262984

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.